HIV and STD Unit, Infectious Disease Service
Our HIV and STD Unit have been involved in the management of HIV-infected patients since 1985. During all these years, we have acquired a vast experience in diagnosing and treating HIV and its complications. We participated and organized hundreds of national and international clinical trials regarding multiple aspects such as efficacy and tolerability of antiretroviral therapy, opportunistic infections and others. In addition to CORIS, we participate in the PISCIS cohort and through it in international cohorts such as COHERE (Collaboration of Observational HIV Epidemiological Research in Europe) and ART-CC (Antiretroviral Therapy Cohort Collaboration).
We have also participated in several expert panels for the Guidelines of management of opportunistic infections (NIH/CDC/IDSA), antiretroviral therapy (GESIDA), opportunistic infections (GESIDA), and neurocognitive disorders (GESIDA)
Our main areas of research are:
- Antiretroviral therapy. Phase II-IV studies. Efficacy and tolerability. New compounds. PrEP. For a better knowledge and use of ARV drugs and regimens before and after their approval, including new prevention strategies.
- Antiviral activity and pharmacology in viral reservoirs such as genital compartments and cerebrospinal fluid. To understand the role of different ARV compounds in viral “sanctuaries”: trying to prevent and treat neurocognitive disorders and reduce sexual transmission of HIV
- Cardiovascular risk in HIV patients. A frequent complication of HIV infected patients related to traditional CVR factors, inflammation and drug toxicity.
- Neurocognitive disorders secondary to HIV infection. CNS is a target of HIV since the beginning of the viral entry.
- Human Papilloma Virus infection and prevention of anal cancer. A frequent infection which may lead to severe complications such as anal cancer.
- Sexually transmitted diseases, diagnosis and treatment. A new and growing epidemic in HIV-infected patients mainly in MSM and those engaged in the so called “chemsex”
Our team is composed by 8 physicians/clinical researchers, two nurses, one health care assistant, one psychologist, 3 clinical trials coordinators, one dietitian and 1 statistician. The Unit is located in the 3rd floor building known as Ex- escuela de enfermeria, within the Hospital Universitari de Bellvitge and it is opened from 7.30 to 17.30 hs from Mondays to Fridays.